Illumina | ILMN - Net Income


Illumina reported $207M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
Boston Scientific USD 907M 434M Jun/2026
Bruker USD -62.9M 66.4M Jun/2026
Charles River Laboratories USD -1.48M 13.36M Jun/2026
Danaher USD 870M 159M Jun/2026
Dentsply International USD -10M 136M Mar/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Illumina USD 207M 73M Jun/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Laboratory Of America USD 298.7M 20.9M Jun/2026
Mettler Toledo International USD 232.9M 63.44M Jun/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 320M 69M Jun/2026
Quidel USD -91.8M 38.9M Mar/2026
Repligen USD 5.01M 3.32M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Standard Biotools USD 127.07M 107.78M Mar/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Waters USD -136M 64M Jun/2026